Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.88 |
| ▸ | LMNA | P02545 | 2/20 | 0.88 |
| ▸ | MEN1 | O00255 | 2/20 | 0.88 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.88 |
| ▸ | USP2 | O75604 | 1/20 | 0.88 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.88 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.88 |
| ▸ | CASP1 | P29466 | 1/20 | 0.88 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.88 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 0.88 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.88 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | APP | P05067 | 5/20 | 0.49 |
| ▸ | RARB | P10826 | 2/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | RARA | P10276 | 1/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16021972 | 1.00 | ALDH1A1 (0.88) | ALDH1A1LMNAMEN1KMT2AUSP2 | |
| SCHEMBL16021961 | 1.00 | ALDH1A1 (0.88) | ALDH1A1LMNAMEN1KMT2AUSP2 | |
| SCHEMBL16021960 | 1.00 | ALDH1A1 (0.88) | ALDH1A1LMNAMEN1KMT2AUSP2 | |
| SCHEMBL5143990 | 1.00 | ALDH1A1 (0.88) | ALDH1A1LMNAMEN1KMT2AUSP2 | |
| SCHEMBL5143711 | 1.00 | ALDH1A1 (0.88) | ALDH1A1LMNAMEN1KMT2AUSP2 | |
| SCHEMBL16021978 | 1.00 | ALDH1A1 (0.88) | ALDH1A1LMNAMEN1KMT2AUSP2 | |
| SCHEMBL17806183 | 0.95 | MEN1 (0.97) | ALDH1A1LMNAMEN1KMT2AUSP2 | |
| SCHEMBL905498 | 0.94 | MEN1 (1.00) | ALDH1A1LMNAMEN1KMT2AUSP2 | |
| SCHEMBL5144071 | 0.94 | MEN1 (1.00) | ALDH1A1LMNAMEN1KMT2AUSP2 | |
| SCHEMBL5144176 | 0.94 | MEN1 (1.00) | ALDH1A1LMNAMEN1KMT2AUSP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3770154-B1 | GLYCOLIDE PRODUCTION METHOD | KUREHA CORP (JP) | 2025-02-19 | — | — | EP | disclosed |
| US-20240182397-A1 | METHOD FOR PRODUCING GLYCOLIDE | KUREHA CORPORATION (JP) | 2024-06-06 | — | — | US | disclosed |
| EP-4310078-A1 | METHOD FOR PRODUCING GLYCOLIDE | Kureha Corporation (JP) | 2024-01-24 | — | — | EP | disclosed |
| CN-116897151-A | Process for producing glycolide | 株式会社吴羽 | 2023-10-17 | — | — | CN | disclosed |
| US-11753391-B2 | Method for producing glycolide | KUREHA CORPORATION (JP) | 2023-09-12 | — | — | US | disclosed |
| CN-111741952-B | Process for producing glycolide | 株式会社吴羽 | 2023-06-09 | — | — | CN | disclosed |
| EP-3770153-B1 | METHOD FOR PRODUCING GLYCOLIDE | KUREHA CORP (JP) | 2022-12-28 | — | — | EP | disclosed |
| WO-2022196178-A1 | METHOD FOR PRODUCING GLYCOLIDE | 株式会社クレハ | 2022-09-22 | — | — | WO | disclosed |
| US-11078179-B2 | Method for producing cyclic ester | KUREHA CORPORATION (JP) | 2021-08-03 | — | — | US | disclosed |
| US-11046665-B2 | Method for producing α-hydroxycarboxylic acid dimeric cyclic ester | KUREHA CORPORATION (JP) | 2021-06-29 | — | — | US | disclosed |
| US-7235673-B2 | Glycolide production process, and glycolic acid oligomer for glycolide production | KUREHA CORPORATION (JP) | 2007-06-26 | — | — | US | disclosed |
| EP-1366037-B1 | GLYCOLIDE PRODUCTION PROCESS, AND GLYCOLIC ACID COMPOSITION | KUREHA CHEMICAL IND CO LTD (JP) | 2005-08-24 | — | — | EP | disclosed |
| US-6891048-B2 | Glycolide production process, and glycolic acid composition | KUREHA KAGAKU KOGYO KK (JP) | 2005-05-10 | — | — | US | disclosed |
| EP-1377566-B1 | GLYCOLIDE PRODUCTION PROCESS, AND GLYCOLIC ACID OLIGOMER FOR GLYCOLIDE PRODUCTION | KUREHA CHEMICAL IND CO LTD (JP) | 2004-09-22 | — | — | EP | disclosed |
| US-20040122240-A1 | Glycolide production process, and glycolic acid oligomer for glycolide production | KUREHA CORPORATION (JP) | 2004-06-24 | — | — | US | disclosed |
| US-20040087805-A1 | Glycolide production process, and glycolic acid composition | KUREHA CORPORATION (JP) | 2004-05-06 | — | — | US | disclosed |
| EP-1377566-A1 | GLYCOLIDE PRODUCTION PROCESS, AND GLYCOLIC ACID OLIGOMER FOR GLYCOLIDE PRODUCTION | Kureha Chemical Industry Co., Ltd. (JP) | 2004-01-07 | — | — | EP | disclosed |
| EP-1366037-A2 | GLYCOLIDE PRODUCTION PROCESS, AND GLYCOLIC ACID COMPOSITION | KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 2003-12-03 | — | — | EP | disclosed |
| WO-2002083661-A1 | GLYCOLIDE PRODUCTION PROCESS, AND GLYCOLIC ACID OLIGOMER FOR GLYCOLIDE PRODUCTION | KUREHA CHEMICAL INDUSTRY COMPANY, LIMITED (JP) | 2002-10-24 | — | — | WO | disclosed |
| WO-2002070508-A2 | GLYCOLIDE PRODUCTION PROCESS, AND GLYCOLIC ACID COMPOSITION | KUREHA KAGAKU KOGYO K.K. (JP) | 2002-09-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040087805-A1 | Glycolide production process, and glycolic acid composition | DDOST, DAD1, AGL | ALDH1A1 3923/4885LMNA 3266/4885MEN1 4085/4885 |
| US-11078179-B2 | Method for producing cyclic ester | SCD, DECR2, PDIA4 | ALDH1A1 1037/4885LMNA 1177/4885MEN1 3721/4885 |
| US-20040122240-A1 | Glycolide production process, and glycolic acid oligomer for glycolide production | UGCG, DAD1, DDOST | ALDH1A1 1400/4885LMNA 3079/4885MEN1 4170/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.